MPN Tumor Board
CME Dinner Symposium
Earn 3.0 CME Credits
Friday, December 6
Dinner & Registration:
6:00 PM-7:00 PM
Program:
7:00 PM-10:00 PM
Hyatt Regency Orlando
Plaza I-K
Convention Level
9801 International Drive
Orlando, FL 32819

Overview:

  • Evaluate risk scoring algorithms and the evolving role of molecular profiling in myeloproliferative neoplasms (MPNs), including primary myelofibrosis and polycythemia vera
  • Integrate trial findings into clinical cases to better manage your patients with MPNs
  • Analyze ongoing clinical trials across MPNs and assess the potential for enrolling specific groups of patients in these studies

Program Chair:

Ronald Hoffman, MD
Albert A. and Vera G. List Professor of Medicine
Director, Myeloproliferative Disorders Research Program
Tisch Cancer Institute
Mount Sinai School of Medicine
New York, NY

This activity is supported by a educational grants from Incyte Corporation and PharmaEssentia USA.
GvHD: Evolving Treatment Landscape
CME Dinner Symposium
Earn 3.0 CME Credits
Friday, December 6
Dinner & Registration:
6:00 PM-7:00 PM
Program:
7:00 PM-10:00 PM
Hyatt Regency Orlando
Plaza H
Convention Level
9801 International Drive
Orlando, FL 32819

Overview:

  • Explore biomarkers for GvHD
  • Discover novel strategies for GvHD prophylaxis
  • Examine emerging therapies for GvHD

Program Chair:

Corey S. Cutler, MD, MPH, FRCPC
Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, MA

This activity is supported by educational grants from Incyte Corporation, Jazz Pharmaceuticals, Kadmon Corporation, LLC, Mallinckrodt Pharmaceuticals, and Takeda Oncology.
HLH: 21st Century Management
CME Lunch Symposium
Earn 2.0 CME Credits
Friday, December 6
Lunch & Registration:
12:30 PM-1:30 PM
Program:
1:30 PM-3:30 PM
Rosen Centre Hotel
Grand Ballroom DE
Ballroom Level
9840 International Drive
Orlando, FL 32819

Overview:

  • Hear the latest information on novel treatments for HLH
  • Learn how the experts apply the latest data
  • Interact with our expert panel to discuss HLH management

Program Chair:

Michelle L. Hermiston, MD, PhD
Associate Professor
Department of Pediatrics
UCSF School of Medicine
Pediatric Hematologist and Oncologist
Benioff Children's Hospital
University of California, San Francisco
San Francisco, CA

This activity is supported by an educational grant from Swedish Orphan Biovitrum AB.
Case Studies in AYA/Adult ALL
CME Lunch Symposium
Earn 3.0 CME Credits
Friday, December 6
Lunch & Registration:
12:30 PM-1:30 PM
Program:
1:30 PM-4:30 PM
Hyatt Regency Orlando
Plaza H
Convention Level
9801 International Drive
Orlando, FL 32819

Overview:

  • Hear the latest information on novel treatments for HLH
  • Learn how the experts apply the latest data
  • Interact with our expert panel to discuss HLH management

Program Chair:

Elias Jabbour, MD
Professor of Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

This activity is supported by educational grants from Amgen Inc., Pfizer, Inc., and Takeda Oncology.
Emerging Paradigms: R/R DLBCL
CME Lunch Symposium
Earn 3.0 CME Credits
Friday, December 6
Lunch & Registration:
12:30 PM-1:30 PM
Program:
1:30 PM-4:30 PM
Rosen Centre Hotel
Grand Ballroom C
Ballroom Level
9840 International Drive
Orlando, FL 32819

Overview:

  • Discover agents that are in late stages of clinical development for relapsed/refractory DLBCL
  • Collaborate with lead clinical trial investigators that determine the efficacy and safety of novel agents for relapsed/refractory DLBCL
  • Prepare to incorporate novel therapeutics into current treatment strategies for your most difficult cases, including patients that are ineligible for stem cell transplant

Program Chair:

Gilles A. Salles, MD, PhD
Professor of Medicine and Hematology
Claude Bernard University of Lyon
Head of the Department of Hematology
Lyon-Sud University Hospital Complex
Pierre-Bnite, France

This activity is supported by an educational grant from MorphoSys AG.